Hot topics close
 

GW Pharmaceuticals

GW Pharma Reports Preliminary Q4 Revenue Of $108M, 'Exceptional' Launch Year For Epidiolex
7
  • GW Pharma Reports Preliminary Q4 Revenue Of $108M, 'Exceptional' Launch Year For Epidiolex
  • GW Pharmaceuticals Receives Positive NICE Recommendation for ...
  • GW Pharmaceuticals Receives Positive NICE Recommendation for EPIDYOLEX (Cannabidiol)
  • GW sets its sights on Zogenix and a new Epidiolex use
  •  
  • GW Pharma shares soar 9% premarket as Oppenheimer upgrades to outperform
  • Oppenheimer Upgrades GW Pharma (GWPH) to Outperform
  • GW Pharmaceuticals Plc (GWPH) Stock Price, Quote, History & News
This week's most popular news